NR2F6_HUMAN - dbPTM
NR2F6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NR2F6_HUMAN
UniProt AC P10588
Protein Name Nuclear receptor subfamily 2 group F member 6
Gene Name NR2F6
Organism Homo sapiens (Human).
Sequence Length 404
Subcellular Localization Nucleus .
Protein Description Transcription factor predominantly involved in transcriptional repression. Binds to promoter/enhancer response elements that contain the imperfect 5'-AGGTCA-3' direct or inverted repeats with various spacings which are also recognized by other nuclear hormone receptors. Involved in modulation of hormonal responses. Represses transcriptional activity of the lutropin-choriogonadotropic hormone receptor/LHCGR gene, the renin/REN gene and the oxytocin-neurophysin/OXT gene. Represses the triiodothyronine-dependent and -independent transcriptional activity of the thyroid hormone receptor gene in a cell type-specific manner. The corepressing function towards thyroid hormone receptor beta/THRB involves at least in part the inhibition of THRB binding to triiodothyronine response elements (TREs) by NR2F6. Inhibits NFATC transcription factor DNA binding and subsequently its transcriptional activity. Acts as transcriptional repressor of IL-17 expression in Th-17 differentiated CD4(+) T cells and may be involved in induction and/or maintenance of peripheral immunological tolerance and autoimmunity. Involved in development of forebrain circadian clock; is required early in the development of the locus coeruleus (LC)..
Protein Sequence MAMVTGGWGGPGGDTNGVDKAGGYPRAAEDDSASPPGAASDAEPGDEERPGLQVDCVVCGDKSSGKHYGVFTCEGCKSFFKRSIRRNLSYTCRSNRDCQIDQHHRNQCQYCRLKKCFRVGMRKEAVQRGRIPHSLPGAVAASSGSPPGSALAAVASGGDLFPGQPVSELIAQLLRAEPYPAAAGRFGAGGGAAGAVLGIDNVCELAARLLFSTVEWARHAPFFPELPVADQVALLRLSWSELFVLNAAQAALPLHTAPLLAAAGLHAAPMAAERAVAFMDQVRAFQEQVDKLGRLQVDSAEYGCLKAIALFTPDACGLSDPAHVESLQEKAQVALTEYVRAQYPSQPQRFGRLLLRLPALRAVPASLISQLFFMRLVGKTPIETLIRDMLLSGSTFNWPYGSGQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MAMVTGGWGGPG
---CCCCCCCCCCCC
19.5223401153
15PhosphorylationWGGPGGDTNGVDKAG
CCCCCCCCCCCCCCC
36.8323401153
32PhosphorylationPRAAEDDSASPPGAA
CCCCCCCCCCCCCCC
42.8630278072
34PhosphorylationAAEDDSASPPGAASD
CCCCCCCCCCCCCCC
35.2623401153
40PhosphorylationASPPGAASDAEPGDE
CCCCCCCCCCCCCCC
36.5023401153
83PhosphorylationCKSFFKRSIRRNLSY
HHHHHHHHHHHHHCH
22.4910713182
89PhosphorylationRSIRRNLSYTCRSNR
HHHHHHHCHHCCCCC
23.1927251275
110PhosphorylationHHRNQCQYCRLKKCF
HHHHHHHHHHHHHHH
6.2828152594
134PhosphorylationQRGRIPHSLPGAVAA
HCCCCCCCCCCCHHH
30.7927174698
142PhosphorylationLPGAVAASSGSPPGS
CCCCHHHCCCCCCHH
26.0420068231
143PhosphorylationPGAVAASSGSPPGSA
CCCHHHCCCCCCHHH
38.2720068231
145PhosphorylationAVAASSGSPPGSALA
CHHHCCCCCCHHHHH
29.8429496963
149PhosphorylationSSGSPPGSALAAVAS
CCCCCCHHHHHHHHC
26.3620068231
156PhosphorylationSALAAVASGGDLFPG
HHHHHHHCCCCCCCC
36.3927174698
167PhosphorylationLFPGQPVSELIAQLL
CCCCCCHHHHHHHHH
33.1120068231
291UbiquitinationAFQEQVDKLGRLQVD
HHHHHHHHHCCCCCC
54.7221906983
330UbiquitinationHVESLQEKAQVALTE
HHHHHHHHHHHHHHH
31.03-
336PhosphorylationEKAQVALTEYVRAQY
HHHHHHHHHHHHHHC
18.6120068231
338PhosphorylationAQVALTEYVRAQYPS
HHHHHHHHHHHHCCC
7.0420068231
343PhosphorylationTEYVRAQYPSQPQRF
HHHHHHHCCCCCCHH
12.1324043423
345PhosphorylationYVRAQYPSQPQRFGR
HHHHHCCCCCCHHHH
49.9424043423
379UbiquitinationFFMRLVGKTPIETLI
HHHHHHCCCCHHHHH
43.5821906983
380PhosphorylationFMRLVGKTPIETLIR
HHHHHCCCCHHHHHH
24.46-
384PhosphorylationVGKTPIETLIRDMLL
HCCCCHHHHHHHHHH
28.36-
392PhosphorylationLIRDMLLSGSTFNWP
HHHHHHHHCCCCCCC
27.08-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
83SPhosphorylationKinasePRKCAP17252
GPS
83SPhosphorylationKinasePRKCDQ05655
GPS
83SPhosphorylationKinasePRKCQQ04759
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NR2F6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NR2F6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NCOA1_HUMANNCOA1physical
10713182
GCR_HUMANNR3C1physical
10713182
THB_HUMANTHRBphysical
10713182
ESR1_HUMANESR1physical
10713182
COT2_HUMANNR2F2physical
15604093
NP1L1_HUMANNAP1L1physical
20195357
CBX1_HUMANCBX1physical
20195357
BC11A_HUMANBCL11Aphysical
23975195

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NR2F6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND SER-40, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY.
"The nuclear orphan receptor NR2F6 suppresses lymphocyte activationand T helper 17-dependent autoimmunity.";
Hermann-Kleiter N., Gruber T., Lutz-Nicoladoni C., Thuille N.,Fresser F., Labi V., Schiefermeier N., Warnecke M., Huber L.,Villunger A., Eichele G., Kaminski S., Baier G.;
Immunity 29:205-216(2008).
Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-83.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34, AND MASSSPECTROMETRY.

TOP